MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Stryker Corp

Geschlossen

BrancheGesundheitswesen

368.07 -2.53

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

361.35

Max

377.22

Schlüsselkennzahlen

By Trading Economics

Einkommen

-288M

546M

Verkäufe

946M

6.4B

KGV

Branchendurchschnitt

48.094

63.778

EPS

4.01

Dividendenrendite

0.9

Gewinnspanne

8.484

Angestellte

53,000

EBITDA

385M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+15.32% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.90%

2.39%

Nächstes Ergebnis

29. Apr. 2025

Nächste Dividendenausschüttung

30. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-8.2B

142B

Vorheriger Eröffnungskurs

370.6

Vorheriger Schlusskurs

368.07

Nachrichtenstimmung

By Acuity

19%

81%

36 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Stryker Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Jan. 2025, 21:55 UTC

Ergebnisse

Stryker Sees Further Organic Sales Growth in 2025

28. Jan. 2025, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6. Jan. 2025, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6. Jan. 2025, 21:39 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19. Feb. 2025, 13:53 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19. Feb. 2025, 13:30 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28. Jan. 2025, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28. Jan. 2025, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28. Jan. 2025, 21:08 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28. Jan. 2025, 21:08 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28. Jan. 2025, 21:06 UTC

Ergebnisse

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28. Jan. 2025, 21:06 UTC

Ergebnisse

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28. Jan. 2025, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Net $500M >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Adj EPS $4.01 >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Net $546M >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Net $500M >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Sales $6.4B >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q EPS $1.41 >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Adj EPS $4.01 >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q EPS $1.41 >SYK

28. Jan. 2025, 21:05 UTC

Ergebnisse

Stryker 4Q Sales $6.4B >SYK

17. Jan. 2025, 21:20 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13. Jan. 2025, 19:30 UTC

Ergebnisse

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7. Jan. 2025, 09:58 UTC

Heiße Aktien

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6. Jan. 2025, 22:03 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6. Jan. 2025, 21:49 UTC

Akquisitionen, Fusionen, Übernahmen

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6. Jan. 2025, 21:24 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6. Jan. 2025, 21:11 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6. Jan. 2025, 21:10 UTC

Akquisitionen, Fusionen, Übernahmen

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Peer-Vergleich

Kursveränderung

Stryker Corp Prognose

Kursziel

By TipRanks

15.32% Vorteil

12-Monats-Prognose

Durchschnitt 435.3 USD  15.32%

Hoch 465 USD

Tief 400 USD

Basierend auf 22 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Stryker Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

22 ratings

18

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

374.61 / 378.05Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Neutral Evidence

Stimmung

By Acuity

36 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.